U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07135687) titled 'Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction' on Aug. 14.
Brief Summary: he purpose of this study to investigate the effect of using losartan (a blood pressure lowering drug with anti-scarring properties) on preventing primary postoperative arthrofibrosis (formation of abnormal scar tissue) in the knees in participants undergoing anterior cruciate ligament (ACL) repair surgery of their knee.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
ACL Injury
ACL Reconstruction
Scar Formation
Intervention:
DRUG: Losartan
Two types of losartan capsules will b...